Procurement Summary
Country : USA
Summary : Sublingual Immunotherapy (Slit) for U.S. Naval Hospital Yokosuka, Japan
Deadline : 16 May 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 100735319
Document Ref. No. : HT941024N0065
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Purchaser : DEPT OF DEFENSE
Contracting Office Address : FALLS CHURCH, VA 22042
Primary Point of Contact : Marcela Cervantes
marcela.cervantes.civ@health.mil
USA
Email :marcela.cervantes.civ@health.mil
Tender Details
Description
THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Western Markets Contracting Division (WMCD), San Diego, intends to negotiate and award a firm fixed price contract for Sublingual Immunotherapy (SLIT) from Allergy Choices, Inc. in accordance with Federal Acquisition Regulation (FAR) 13.106-1(b)(1)(i), only one source being available to meet the Government-s needs, to:
Allergy Choices, Inc.
2731 National Dr.
Onalaska, WI 54650-8784
The North American Industry Classification System (NAICS) code for this requirement is 325412 - Pharmaceutical Preparation Manufacturing; the business size standard is 1, 300 employees. The Product Service Code (PSC) is 6505 - Drugs and Biologicals.
The US Naval Hospital Yokosuka provides medical readiness for U.S. Pacific Fleet. Having a dedicated contracted SLIT support for US Naval Hospital Yokosuka will allow uninterrupted operational support for the waterfront.
The objective of this sole source award is to procure SLIT consumables (listed below). Allergy Choices, Inc.
doesn-t have distributors for their products and ship directly to consumers.
Consumables:
Item#
Description
QTY (EA)
Ultimate Delivery Date
Base Year
Inhalant (red) Mult-Allergen
1-20 Antigens One 15Mil Vial (90 Day Sypply)
120
9/30/2025
Option 1
Inhalant (red) Mult-Allergen
1-20 Antigens One 15Mil Vial (90 Day Sypply)
120
9/30/2026
Option 2
Inhalant (red) Mult-Allergen
1-20 Antigens One 15Mil Vial (90 Day Sypply)
120
9/30/2027
Option 3
Inhalant (red) Mult-Allergen
1-20 Antigens One 15Mil Vial (90 Day Sypply)
120
9/30/2028
Option 4
Inhalant (red) Mult-Allergen
1-20 Antigens One 15Mil Vial (90 Day Sypply)
120
9/...
Active Contract Opportunity Notice ID HT941024N0065 Related Notice Department/Ind. Agency DEPT OF DEFENSE Sub-tier DEFENSE HEALTH AGENCY (DHA) Office DEFENSE HEALTH AGENCY
General Information
Contract Opportunity Type: Special Notice (Updated)
All Dates/Times are: (UTC-07:00) PACIFIC STANDARD TIME, LOS ANGELES, USA
Updated Published Date: May 01, 2024 01:45 pm PDT
Original Published Date: May 01, 2024 01:44 pm PDT
Updated Response Date: May 16, 2024 11:00 am PDT
Original Response Date: May 16, 2024 11:00 am PDT
Inactive Policy: 15 days after response date
Updated Inactive Date: May 31, 2024
Original Inactive Date: May 31, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Place of Performance: Yokosuka, JP-37 JPN
Documents
Tender Notice
Notice-of-Intent-to-Sole-Source--SLIT.pdf